DuPont de Nemours (DD)
(Delayed Data from NYSE)
$87.54 USD
+0.40 (0.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $87.52 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$87.54 USD
+0.40 (0.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $87.52 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Zacks News
DuPont (DD) and Point Blank Collaborate for Kevlar EXO
by Zacks Equity Research
DuPont's (DD) Kevlar has long been the advanced material used in high-performance body armor designed to protect people who serve.
DuPont (DD) Announces Preliminary Q4 Results & Q1 2024 Outlook
by Zacks Equity Research
DuPont (DD) projects Q4 challenges due to lower volumes and weak demand, implements restructuring for cost savings and expresses confidence in semiconductor stabilization.
Here's Why You Should Add DuPont (DD) to Your Portfolio Now
by Zacks Equity Research
DuPont (DD) benefits from innovation, the Spectrum Plastics acquisition and pricing and productivity actions.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) gains on its focus on growth though innovation, the Spectrum Plastics acquisition and productivity actions amid headwinds from soft demand in certain markets.
Chemours (CC), DuPont & Corteva Back U.S. Water System Deal
by Zacks Equity Research
Chemours (CC), DuPont & Corteva do not intend to exercise the opt-out option and extend support to PFAS Deal with the U.S. Water System.
The Zacks Analyst Blog Highlights Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours
by Zacks Equity Research
Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours are part of the Zacks top Analyst Blog.
DuPont (DD) Gains on Innovation and Spectrum Plastics Buyout
by Zacks Equity Research
While DuPont (DD) faces headwinds from sluggishness in some markets, it benefits from innovation, the Spectrum Plastics acquisition and pricing and productivity actions.
DuPont (DD) Launches Tedlar PVF Solutions and PVF Coating
by Zacks Equity Research
DuPont (DD) collaborates closely with Coryor to launch the printed PVF film solutions on display in the Taipei Building Show.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
DuPont (DD) gains on its focus on growth though innovation, the Spectrum Plastics acquisition and pricing and productivity actions amid headwinds from the sluggishness in specific markets.
Why Is DuPont de Nemours (DD) Up 5% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DuPont (DD) Attains Full Conversion to Low-GWP Styrofoam
by Zacks Equity Research
DuPont's (DD) joint efforts have considerably reduced the carbon footprint of its Styrofoam portfolio.
Here's Why DuPont de Nemours (DD) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DuPont (DD) Fortilife NF1000 Membrane Now Available Globally
by Zacks Equity Research
Fortilife NF1000 by DuPont (DD) offers demanding separations in high-pressure industrial wastewater applications.
DuPont's (DD) Tyvek Facility Obtains ISCC PLUS Certification
by Zacks Equity Research
DuPont (DD) gets permission from ISCC PLUS to use sustainable raw materials produced from renewable and recycled sources.
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours and Methanex
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours and Methanex are part of the Zacks Industry Outlook article.
3 Diversified Chemical Stocks to Watch Amid Demand Worries
by Anindya Barman
Weak demand in certain markets, destocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DD and MEOH are poised to navigate the industry challenges.
DuPont (DD) Opens New Kalrez Manufacturing Site in Delaware
by Zacks Equity Research
The new Tralee Park Annex facility will significantly increase DuPont (DD) Kalrez perfluoroelastomer components capacity.
DuPont's (DD) Q3 Earnings Surpass Estimates, Revenues Lag
by Zacks Equity Research
DuPont's (DD) earnings top estimates in Q3 amid lower volumes.
Compared to Estimates, DuPont de Nemours (DD) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for DuPont de Nemours (DD) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DuPont de Nemours (DD) Tops Q3 Earnings Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 9.52% and 2.85%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Gears Up for Q3 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from firm demand in several industrial markets and its pricing and productivity actions in the third quarter.
DuPont de Nemours (DD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) Benefits From Cost Cuts and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
DuPont (DD) Unveils Low-Cyclics Silicone Soft Skin Adhesive
by Zacks Equity Research
The adhesive is created as part of DuPont's (DD) efforts to broaden its portfolio of solutions to support the expanding medical device market.
US Steel (X), DuPont Launch COASTALUME for Coastal Environment
by Zacks Equity Research
U.S. Steel (X) and DuPont create a maintenance-free roofing solution using GALVALUME and Tedlar PVF film for the first time.